1. Home
  2. EVO vs KSS Comparison

EVO vs KSS Comparison

Compare EVO & KSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVO
  • KSS
  • Stock Information
  • Founded
  • EVO 1993
  • KSS 1962
  • Country
  • EVO Germany
  • KSS United States
  • Employees
  • EVO N/A
  • KSS N/A
  • Industry
  • EVO Biotechnology: Pharmaceutical Preparations
  • KSS Department/Specialty Retail Stores
  • Sector
  • EVO Health Care
  • KSS Consumer Discretionary
  • Exchange
  • EVO Nasdaq
  • KSS Nasdaq
  • Market Cap
  • EVO 1.6B
  • KSS 1.4B
  • IPO Year
  • EVO 2021
  • KSS 1992
  • Fundamental
  • Price
  • EVO $3.60
  • KSS $6.48
  • Analyst Decision
  • EVO Buy
  • KSS Sell
  • Analyst Count
  • EVO 2
  • KSS 12
  • Target Price
  • EVO $5.90
  • KSS $10.57
  • AVG Volume (30 Days)
  • EVO 101.3K
  • KSS 14.2M
  • Earning Date
  • EVO 04-17-2025
  • KSS 05-29-2025
  • Dividend Yield
  • EVO N/A
  • KSS 25.04%
  • EPS Growth
  • EVO N/A
  • KSS N/A
  • EPS
  • EVO N/A
  • KSS 0.98
  • Revenue
  • EVO $825,103,013.00
  • KSS $16,221,000,000.00
  • Revenue This Year
  • EVO $3.70
  • KSS N/A
  • Revenue Next Year
  • EVO $10.32
  • KSS N/A
  • P/E Ratio
  • EVO N/A
  • KSS $6.61
  • Revenue Growth
  • EVO 1.99
  • KSS N/A
  • 52 Week Low
  • EVO $2.84
  • KSS $6.04
  • 52 Week High
  • EVO $7.77
  • KSS $28.25
  • Technical
  • Relative Strength Index (RSI)
  • EVO 56.15
  • KSS 37.96
  • Support Level
  • EVO $3.27
  • KSS $6.04
  • Resistance Level
  • EVO $3.40
  • KSS $6.96
  • Average True Range (ATR)
  • EVO 0.14
  • KSS 0.76
  • MACD
  • EVO 0.07
  • KSS 0.00
  • Stochastic Oscillator
  • EVO 84.44
  • KSS 16.67

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About KSS Kohl's Corporation

Kohl's operates about 1,176 department stores in 49 states that sell moderately priced private-label and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most of these stores are in strip centers. Kohl's also operates a large digital sales business. Women's apparel is Kohl's largest category, having generated 26% of its 2023 sales. The retailer, headquartered in Menomonee Falls, Wisconsin, opened its first department store in 1962.

Share on Social Networks: